CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Medivir AB Company Snapshot
Medivir AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medivir AB with three other companies in this sector in Sweden: Active Biotech AB (2018 sales of 20.05 million Swedish Kronor [US$2.10 million] of which 80% was Rental revenues), Alligator Bioscience Ab (26.96 million Swedish Kronor [US$2.83 million] of which 94% was Biosynergy), and Xbrane Biopharma Ab (20.49 million Swedish Kronor [US$2.15 million] of which 380% was Biosimilars).

Sales Analysis. Medivir AB reported sales of SEK 23.86 million (US$2.50 million) for the year ending December of 2018. This represents a sharp decrease of 34.9% versus 2017, when the company's sales were SEK 36.64 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Medivir AB
  Stock Performance Chart for Medivir AB
 
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 19.56
(Figures in Swedish Kronor)
1 Week -13.3%   13 Weeks -14.6%  
4 Weeks -13.5%   52 Weeks -31.5%  
 
Medivir AB Key Data:
  Ticker: MVIR-B Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 23,863,000
(Year Ending Jan 2019).
Employees: 75
  Currency: Swedish Kronor Market Cap: 475,073,280
  Fiscal Yr Ends: December Shares Outstanding: 24,288,000
  Share Type: B Fri Aktie Closely Held Shares: 4,197,322
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.